Ambry Genetics, a leader in genetic testing, and a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), announced the publication of a peer-reviewed study in Genetics in Medicine (GIM), the ...
Research underscores clinical utility of RNA sequencing in providing critical insights to drive diagnoses and medical ...
Tempus AI (NASDAQ:TEM) shares are trading higher Monday after the company announced its subsidiary, Ambry Genetics, published ...
GeneDx Holdings (WGS) is poised for growth with strong Q2 results and SaaS transition. Read here for an investment analysis.
Systemic sclerosis (SSc) is a severe autoimmune disease with complex genetic causes. Some genetic contributors have been identified, but others remain unknown, which has impeded development of ...
Congenital diaphragmatic hernia (CDH) is a common, life-threatening birth defect. Often, CDH occurs with other birth defects (CDH+). In a new study, researchers at Baylor College of Medicine have ...
TP53 Gain-of-Function and Non–Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma The study used whole-exome sequencing of tumor sample ...
In an article published in the Journal of Pediatrics, researchers based in Brazil describe the case of a nine-year-old boy admitted to hospital with multiple symptoms and overlapping conditions that ...
MADISON, Wis.--(BUSINESS WIRE)-- The Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC) has standardized its target enrichment human disease research studies on Roche NimbleGen (SIX: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback